Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. 1994

D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

The potential involvement of interleukin-1 (IL-1) in the pathogenesis of experimental rhinovirus colds was examined. Nasal lavages were recovered before and for 5 days after rhinovirus infection from 44 subjects, 22 of whom were randomized to receive prophylaxis with glucocorticoids, while the rest received placebo. Immunoreactive IL-1 beta was significantly increased in subjects who were infected and symptomatic compared with noninfected volunteers or subjects who were infected but asymptomatic. Concentrations of immunoreactive IL-1 beta correlated with levels of kinins and albumin in lavage fluids. Studies of IL-1 bioactivity established that most activity in lavages from infected subjects was IL-1 beta. Glucocorticoid prophylaxis did not inhibit IL-1 production, nor did it significantly affect the symptomatic response to infection or, in a subset of patients, neutrophil infiltration. These data are consistent with the hypothesis that IL-1 could contribute to the pathogenesis of rhinovirus infections.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D008297 Male Males
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D003139 Common Cold A catarrhal disorder of the upper respiratory tract, which may be viral or a mixed infection. It generally involves a runny nose, nasal congestion, and sneezing. Cold, Common,Coryza, Acute,Catarrh,Acute Coryza,Catarrhs,Colds, Common,Common Colds
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012229 Rhinovirus A genus of PICORNAVIRIDAE inhabiting primarily the respiratory tract of mammalian hosts. It includes over 100 human serotypes associated with the COMMON COLD. Common Cold Virus,Coryza Viruses,Cold Virus, Common,Cold Viruses, Common,Common Cold Viruses,Coryza Virus,Rhinoviruses

Related Publications

D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
April 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
October 1994, American journal of respiratory and critical care medicine,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
January 1984, Acta oto-laryngologica. Supplementum,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
May 2005, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
November 1993, The Journal of allergy and clinical immunology,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
August 2000, Journal of clinical microbiology,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
January 1984, Acta oto-laryngologica. Supplementum,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
January 1989, Bulletin of the New York Academy of Medicine,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
October 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
D Proud, and J M Gwaltney, and J O Hendley, and C A Dinarello, and S Gillis, and R P Schleimer
September 1992, The Journal of allergy and clinical immunology,
Copied contents to your clipboard!